4.7 Article

CDC20 promotes radioresistance of prostate cancer by activating Twist1 expression

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy

Bo Hou et al.

Summary: The tumor microenvironment (TME) plays a crucial role in tumor development and progression, and modulating the TME can improve therapy strategies. The interaction between PD-1 protein on T cells and PD-L1 protein on tumor cells contributes to T cell dysfunction and immune response blocking. Recent studies have shown that E3 ubiquitin ligases regulate the expression of PD-1/PD-L1 in the TME, leading to resistance to anti-PD-1/PD-L1 therapy in cancer patients. Targeting E3 ubiquitin ligases to control the levels of PD-1/PD-L1 could enhance the effectiveness of immunotherapy in cancer patients.

FRONTIERS IN IMMUNOLOGY (2023)

Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Review Oncology

Current status and progress of the development of prostate cancer vaccines

Jie Wang et al.

Summary: Currently, common treatments for prostate cancer include surgery, radiation therapy, chemotherapy, and hormone therapy. However, patients often experience high recurrence rates and may develop castration-resistant prostate cancer. Tumor vaccines, which utilize tumor-specific antigens (TSA) and tumor-associated antigens (TAA), aim to activate a specific immune response against cancer cells in the body. Different types of prostate cancer vaccines, such as cellular vaccines, extracellular-based anti-tumor vaccines, polypeptide vaccines, and nucleic acid vaccines, have been developed with the advancement of tumor vaccine technology. This review provides a summary of the current status and progress in the development of prostate cancer vaccines.

JOURNAL OF CANCER (2023)

Article Cell Biology

Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation

Linhui Wu et al.

Summary: Fbxo45 protein promotes pancreatic cancer growth and metastasis by regulating the stability of USP49. Fbxo45 binds to a specific sequence of USP49 through its SPRY domain, and NEK6 kinase enhances Fbxo45-mediated USP49 ubiquitination and degradation.

CELL DEATH & DISEASE (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

The Prognostic Assessment of CDC20 in Patients with Renal Clear Cell Carcinoma and Its Relationship with Body Immunity

Jiaqi Shi et al.

Summary: This article analyzes the relationship between cell division cycle (CDC20) molecules and oncology outcomes in patients with renal clear cell carcinoma (KIRC). The study found that CDC20 was upregulated in KIRC tissues and was associated with shorter overall survival. Additionally, CDC20 expression was related to multiple signaling pathways, tumor mutation burden, immune checkpoint molecules, tumor microenvironment, and immunological infiltration.

CONTRAST MEDIA & MOLECULAR IMAGING (2022)

Article Oncology

Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy

Jinxin Liu et al.

Summary: This review focuses on the molecular mechanisms by which matrix metalloproteinases (MMPs) are regulated by E3 ubiquitin ligases in carcinogenesis, and discusses the therapeutic potential of targeting E3 ubiquitin ligases to inhibit MMPs.

SEMINARS IN CANCER BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Impaired Cdc20 signaling promotes senescence in normal cells and apoptosis in non-small cell lung cancer cells

Daniela Volonte et al.

Summary: The study revealed that Cdc20 and APC/C play crucial roles in cellular senescence, with their downregulation or inhibition leading to premature senescence in lung fibroblasts, but inducing apoptosis in lung cancer cells. Furthermore, the downregulation of securin expression through GSK-3 beta-mediated pathway promotes cell death.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation

Qi Wang et al.

Summary: The study found that Fbxo45 plays an important role in esophageal squamous cell carcinoma (ESCC). Overexpression of Fbxo45 promoted the growth, migration, and invasion of ESCC cells, while inhibiting apoptosis. Furthermore, Fbxo45 exerted its functions by regulating the stability of GGNBP2. High expression of Fbxo45 and low expression of GGNBP2 in ESCC tissues were associated with poor prognosis.

ONCOGENE (2022)

Article Cell Biology

CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma

Qiliu Peng et al.

Summary: By analyzing HCC-related datasets, this study identified HCC-related genes and screened out 8 feature genes associated with patient prognosis using bioinformatics methods. Among them, high expression of CDC20 was correlated with poor prognosis and was related to the cell cycle. In addition, a high degree of infiltration was positively correlated with Th2 and CDC20.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Article Oncology

Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation

Lixia Wang et al.

Summary: The study investigated the molecular mechanisms underlying radioresistance in bladder cancer, revealing elevated Cdc20 expression in IR cells and its role in governing IR-mediated EMT by regulating FoxO1 degradation. Therefore, inhibiting Cdc20 or activating FoxO1 may be potential strategies to overcome radioresistance in bladder cancer.

CANCER LETTERS (2021)

Article Medicine, Research & Experimental

CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer

Liang Dai et al.

Summary: This study identified 106 consistently differentially expressed genes (DEGs) between metastatic prostate cancer (mPCa) and prostate cancer (PCa). These DEGs were significantly enriched in promoting cell proliferation, cell division, and cell adhesion in small cell lung cancer and PCa. The hub genes CDC20 and PTTG1 were associated with poorer disease-free survival in mPCa. Immunohistochemical assay results showed higher expression levels of CDC20 and PTTG1 in mPCa compared with PCa. Migration assay results indicated that CDC20 and PTTG1 could enhance the migration ability of PCa cells. These findings suggest that CDC20 and PTTG1 may serve as therapeutic targets in mPCa research and clinical studies.

ADVANCES IN THERAPY (2021)

Article Biotechnology & Applied Microbiology

Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide

Yiming Ding et al.

Summary: The study showed that apcin effectively inhibits the proliferation of glioma cells, reduces migration, and promotes apoptosis. Furthermore, apcin increases the sensitivity of glioma cells to TMZ.

BIOENGINEERED (2021)

Article Oncology

The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors

Fei Wu et al.

Summary: The expression levels of CDC20 gene were significantly elevated in various types of cancers and positively correlated with clinical stages in multiple cancer types. High expression of CDC20 was associated with poor prognosis in 10 cancer types in the TCGA dataset.

FRONTIERS IN ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

CDC20 regulates the cell proliferation and radiosensitivity of P53 mutant HCC cells through the Bcl-2/Bax pathway

Shuai Zhao et al.

Summary: This study found that CDC20 is highly expressed in HCC and is involved in radio resistance of HCC cells by affecting P53 mutation Bcl-2/Bax signaling pathway, enhancing the sensitivity of HCC to radiation therapy.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Oncology

Downregulation of CDC20 suppressed cell proliferation, induced apoptosis, triggered cell cycle arrest in osteosarcoma cells, and enhanced chemosensitivity to cisplatin

Yi Gao et al.

Summary: In this study, it was found that downregulation of CDC20 inhibited cell proliferation, induced apoptosis, and triggered cell cycle arrest in osteosarcoma cells. In contrast, overexpression of CDC20 promoted cell growth and inhibited apoptosis in normal cells. Targeting CDC20 could be useful for the treatment of osteosarcoma and may provide a promising solution for treating osteosarcoma with cisplatin insensitivity.

NEOPLASMA (2021)

Article Cell Biology

miR-4429 sensitized cervical cancer cells to irradiation by targeting RAD51

Hongbo Sun et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Article Biochemistry & Molecular Biology

Cell division cycle proteinising prognostic biomarker of breast cancer

Lin Cheng et al.

BIOSCIENCE REPORTS (2020)

Review Oncology

NEDD4 E3 ligase: Functions and mechanism in human cancer

Zhi-Wei Wang et al.

SEMINARS IN CANCER BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Downregulation of CDC20 Increases Radiosensitivity through Mcl-1/p-Chk1-Mediated DNA Damage and Apoptosis in Tumor Cells

Yang Gao et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

Rui-Xue Huang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Oncology

Multiple biological functions of Twist1 in various cancers

Zhixiang Zhao et al.

ONCOTARGET (2017)

Review Pharmacology & Pharmacy

Targeting Cdc20 as a novel cancer therapeutic strategy

Lixia Wang et al.

PHARMACOLOGY & THERAPEUTICS (2015)

Article Biochemistry & Molecular Biology

Cyclin A and Nek2A: APC/C-Cdc20 substrates invisible to the mitotic spindle checkpoint

Wouter van Zon et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2010)

Article Biochemistry & Molecular Biology

Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest

Margaret E. Harley et al.

EMBO JOURNAL (2010)

Article Biochemistry & Molecular Biology

DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling

Taraswi Banerjee et al.

NUCLEIC ACIDS RESEARCH (2009)

Review Cardiac & Cardiovascular Systems

Ubiquitin and ubiquitin-like proteins in protein regulation

Joerg Herrmann et al.

CIRCULATION RESEARCH (2007)